Campagna, Maria Pia, Xavier, Alexandre, Lechner-Scott, Jeannette, Maltby, Vicky, Scott, Rodney J., Butzkueven, Helmut, Jokubaitis, Vilija G., Lea, Rodney A.. BioMed Central Ltd.; 2021. Epigenome-wide association studies: current knowledge, strategies and recommendations.

Xavier, Alexandre, Campagna, Maria Pia, Lechner-Scott, Jeannette, Ausimmune Investigator Group,, Maltby, Vicki E., Kilpatrick, Trevor, Taylor, Bruce V., Butzkueven, Helmut, Ponsonby, Anne-Louise, Scott, Rodney J., Jokubaitis, Vilija G., Lea, Rodney A.. Frontiers Research Foundation; 2023. Interferon beta treatment is a potent and targeted epigenetic modifier in multiple sclerosis.

Campagna, Maria Pia, Lechner-Scott, Jeannette, Maltby, Vicki E., Lea, Rodney A., Butzkueven, Helmut, Jokubaitis, Vilija G.. Elsevier; 2023. Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes.

Campagna, Maria Pia, Xavier, Alexandre, Lea, Rodney A., Jokubaitis, Vilija G., Stankovich, Jim, Maltby, Vicki E., Slee, Mark, Yeh, Wei Z., Kilpatrick, Trevor, Scott, Rodney J., Butzkueven, Helmut, Lechner-Scott, Jeannette. BioMed Central (BMC); 2023. Parity is associated with long-term differences in DNA methylation at genes related to neural plasticity in multiple sclerosis.

Jokubaitis, Vilija G., Campagna, Maria Pia, Lea, Rodney, Kilpatrick, Trevor J., Kalincik, Tomas, De Jager, Philip L., Beecham, Ashley, McCauley, Jacob L., Taylor, Bruce V., Vucic, Steve, Laverick, Louise, Vodehnalova, Karolina, Ibrahim, Omar, García-Sanchéz, Maria-Isabel, Alcina, A, van der Walt, A, Havrdova, EK, Izquierdo, G, Patsopoulos, N, Horakova, D, Butzkueven, H, Stankovich, Jim, Kleinova, Pavlina, Matesanz, Fuencisla, Hui, Daniel, Eichau, Sara, Slee, Mark, Lechner-Scott, Jeannette. Oxford University Press; 2023. Not all roads lead to the immune system: the genetic basis of multiple sclerosis severity.

Xavier, Alexandre, Maltby, Vicki E., Jokubaitis, Vilija G., Kilpatrick, Trevor, Alfredsson, Lars, Jagodic, Maja, Ponsonby, Anne-Louise, Taylor, Bruce V., Scott, Rodney J., Lea, Rodney A., Lechner-Scott, Jeannette, Ewing, Ewoud, Campagna, Maria Pia, Burnard, Sean M., Tegner, Jesper N., Slee, Mark, Butzkueven, Helmut, Kockum, Ingrid, Kular, Lara. MDPI AG; 2023. DNA Methylation Signatures of Multiple Sclerosis Occur Independently of Known Genetic Risk and Are Primarily Attributed to B Cells and Monocytes.

Yeh, Wei Zhen, Gresle, Melissa, Sampangi, Sandeep, Campagna, Maria Pia, Stankovich, Jim, Van der Walt, Anneke, Jokubaitis, Vilija, Butzkueven, Helmut, Lea, Rodney, Taylor, Bruce, Lucas, Robyn M., Ponsonby, Anne-Louise, Mason, Deborah, Andrew, Julie, Campbell, Hamish, Morahan, Julia. Academic Press; 2024. The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial.

Campagna, Maria Pia, Havrdova, Eva Kubala, van der Walt, Anneke, Butzkueven, Helmut, Jokubaitis, Vilija G., Horakova, Dana, Izquierdo, Guillermo, Matesanz, Fuencisla, Eichau, Sara, Lechner-Scott, Jeanette, Taylor, Bruce Multiple sclerosis, disease severity, genetics., Garcia-Sanchez, Maria-Isabel, Alcina, Antonio. Sage; 2024. No evidence for association between rs10191329 severity locus and longitudinal disease severity in 1813 relapse-onset multiple sclerosis patients from the MSBase registry.

Campagna, Maria Pia, Xavier, Alexandre, Lea, Rodney A., Stankovich, Jim, Maltby, Vicki E., Butzkueven, Helmut, Lechner-Scott, Jeannette, Scott, Rodney J., Jokubaitis, Vilija G.. BioMed Central (BMC); 2022. Whole-blood methylation signatures are associated with and accurately classify multiple sclerosis disease severity.